TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36072363

Group type: EXPERIMENTAL
Intervention: Gardening sessions (hour-long, twice weekly for two months) with a group donating vegetables to a food pantry
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gardening sessions (hour-long, twice weekly for two months) with a group harvesting produce for personal use
Number of subjects: 10
Study: 34517135

Group type: EXPERIMENTAL
Intervention: 1000 mg methylprednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35674370

Group type: EXPERIMENTAL
Intervention: Web-based self-care program for 6 months
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study: 32520828

Group type: EXPERIMENTAL
Intervention: Prednisone (PRED) plus Azathioprine (AZA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 50
Study: 36132071

Group type: EXPERIMENTAL
Intervention: Machine learning model based on enhanced MRI (T1)
Number of subjects: 120
Study: 34460173

Group type: EXPERIMENTAL
Intervention: Expanded Carrier Screening (ECS)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Usual care carrier screening
Number of subjects: 304
Study: 32029306

Group type: EXPERIMENTAL
Intervention: Half-dose prasugrel (30-mg load followed by 5 mg daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Clopidogrel (600-mg load followed by 75 mg daily)
Number of subjects: 70
Study: 33772375

Group type: EXPERIMENTAL
Intervention: DFVC angle of 4°
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: DFVC angle of 5°
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: DFVC angle of 6°
Number of subjects: 125
Study: 32562057

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (onabotulinumtoxinA)
Number of subjects: 0
Study: 34982842

Group type: EXPERIMENTAL
Intervention: Music-based biofeedback (retraining group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (tempo-synchronized music)
Number of subjects: 20
Study: 34329567

Group type: EXPERIMENTAL
Intervention: Cetagliptin coadministered with metformin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Metformin coadministered with cetagliptin
Number of subjects: 34
Study: 35195257

Group type: EXPERIMENTAL
Intervention: Practice facilitation program for primary care physicians (PCPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group A)
Number of subjects: 0
Study: 32649745

Group type: EXPERIMENTAL
Intervention: National antimicrobial stewardship campaign
Number of subjects: 1482223
Study: 35105594

Group type: EXPERIMENTAL
Intervention: online self-compassion for weight management (SC4WM) intervention + WW programme
Number of subjects: 240

Group type: COMPARATOR
Intervention: WW programme only
Number of subjects: 240
Study: 34099382

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1575
Study: 32858791

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral‐based group therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: No further intervention (control group)
Number of subjects: 300
Study: 34878629

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 646
Study: 33419635

Group type: EXPERIMENTAL
Intervention: Weekly subcutaneous semaglutide
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 36017685

Group type: EXPERIMENTAL
Intervention: Variable Training Group (VTG)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Stable Training Group (STG)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 63
Study: 34403626

Group type: EXPERIMENTAL
Intervention: NMES (neuromuscular electrical stimulation)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: STAND (standing motionless)
Number of subjects: 9

Group type: COMPARATOR
Intervention: SIT (sitting motionless)
Number of subjects: 9
Study: 34462846

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (sleeve gastrectomy or gastric bypass)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Medical weight management (control group)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 403

Group type: COMPARATOR
Intervention: Medical weight management
Number of subjects: 403
Study: 32139110

Group type: EXPERIMENTAL
Intervention: 6 g of legume-based protein
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 8 g of legume-based protein
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 10 g of legume-based protein
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 12 g of legume-based protein
Number of subjects: 100
Study: 35818766

Group type: EXPERIMENTAL
Intervention: Microbiome composition analysis using 16S V4 amplicon next-generation sequencing.
Number of subjects: 0
Study: 34924027

Group type: EXPERIMENTAL
Intervention: Model predicted settings
Number of subjects: 80

Group type: COMPARATOR
Intervention: Best clinical settings
Number of subjects: 80
Study: 35562805

Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL
Number of subjects: 2328

Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL in genotype CC
Number of subjects: 2328

Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL in genotype CT
Number of subjects: 2328

Group type: EXPERIMENTAL
Intervention: 5‐methyltetrahydrofolate ≤ 10 ng/mL in genotype TT
Number of subjects: 2328

Group type: COMPARATOR
Intervention: Comparison of decline in trend between genotypes
Number of subjects: 2328
Study: 33298307

Group type: EXPERIMENTAL
Intervention: Contingency management (CM) training and delivery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Probation services as usual (Control)
Number of subjects: 0
Study: 32532275

Group type: EXPERIMENTAL
Intervention: UMEC 31.25 mcg
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: UMEC 62.5 mcg
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study: 34971833

Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovascular treatment
Number of subjects: 0
Study: 33230010

Group type: EXPERIMENTAL
Intervention: Active-TENS (2-125 Hz; highest-tolerable intensity)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo-TENS
Number of subjects: 258

Group type: COMPARATOR
Intervention: No-TENS
Number of subjects: 258
Study: 33136078

Group type: EXPERIMENTAL
Intervention: Task-specific circuit training (TSCT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Global stretching, memory exercises, and education sessions (Control)
Number of subjects: 36
Study: 35157994

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) plus whole brain radiotherapy (WBRT) (30 Gy in 10 fractions), NTG administered via a transdermal 36 mg patch from Monday to Friday throughout WBRT (10 days)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) plus whole brain radiotherapy (WBRT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Whole brain radiotherapy (WBRT) alone
Number of subjects: 96
Study: 34092489

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation programme (usual care plus 12 weeks of exercise training, pedometer, health education, and text messages)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation programme
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 118
Study: 32102649

Group type: EXPERIMENTAL
Intervention: Leadership training and coaching based on priority institutional health service improvement projects
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-trained managers in comparison institutions
Number of subjects: 15
Study: 35850159

Group type: EXPERIMENTAL
Intervention: Happy facial expressions as target category
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angry, neutral, and happy facial expressions presented in randomized blocks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Happy targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All target conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral targets
Number of subjects: 0
Study: 34936265

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with suspension training
Number of subjects: 105

Group type: COMPARATOR
Intervention: Scalp acupuncture
Number of subjects: 105

Group type: COMPARATOR
Intervention: Suspension training
Number of subjects: 105
Study: 35426776

Group type: EXPERIMENTAL
Intervention: PGE1 (5 ng/kg/min)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PGE1 (5 ng/kg/min) in COVID-19 patients
Number of subjects: 50
Study: 33054984

Group type: EXPERIMENTAL
Intervention: Audio-visual patient information with examples based on an apple farmer (arm I)
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Audio-visual patient information with examples testing a treatment against worms (arm II)
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Audio-visual patient information short version without examples (arm III)
Number of subjects: 1068

Group type: COMPARATOR
Intervention: Standard written information (arm IV)
Number of subjects: 1068
Study: 32497524

Group type: EXPERIMENTAL
Intervention: Low-dose vaccine (3·2 × 10^3 per 0·1 mL)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Medium-dose vaccine (3·2 × 10^4 per 1 mL)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-dose vaccine (3·2 × 10^5 per 1 mL)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All dose groups
Number of subjects: 120
Study: 35830572

Group type: EXPERIMENTAL
Intervention: Intrawound vancomycin powder (1000 mg)
Number of subjects: 980

Group type: COMPARATOR
Intervention: Control group (no topical antibiotics)
Number of subjects: 980
Study: 34939582

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH) treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: non-rhGH treatment
Number of subjects: 70
Study: 32219498

Group type: EXPERIMENTAL
Intervention: Multidisciplinary co-management program
Number of subjects: 3021

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 3021
Study: 36191322

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study: 33559704

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 3163

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 3163

Group type: EXPERIMENTAL
Intervention: Linagliptin and Glimepiride
Number of subjects: 3163
Study: 32306301

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Progressive Resisted Exercise (PRE)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 136
Study: 34957660

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3726
Study: 32928896

Group type: EXPERIMENTAL
Intervention: First hour of continuous video-electroencephalography (cEEG) graded as normal, mildly, moderately, or severely abnormal
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Abnormal cEEG background (excluding those with seizures in the first hour)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Severely abnormal cEEG background (excluding those with seizures in the first hour)
Number of subjects: 266
Study: 35881154

Group type: EXPERIMENTAL
Intervention: Hypohydration (HYPO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 34789638

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement with whey peptides and branched-chain amino acids
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 34205103

Group type: EXPERIMENTAL
Intervention: Deep dry needling in the adductor pollicis muscle
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo needling
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Deep dry needling in the adductor muscle
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Deep dry needling in the anterior tibialis muscle
Number of subjects: 65
Study: 36397087

Group type: EXPERIMENTAL
Intervention: Letter sent from family doctor to parents informing them of the importance of asthma preventer medication during summer holidays.
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Informing GP practices of the PLEASANT study findings with recommendations.
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Cost-saving per patient over the year.
Number of subjects: 1279
Study: 34265789

Group type: EXPERIMENTAL
Intervention: CGI VR
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Video Capture VR
Number of subjects: 103

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 103
Study: 32485641

Group type: EXPERIMENTAL
Intervention: 25% caloric restriction (CR) for two years
Number of subjects: 220

Group type: COMPARATOR
Intervention: Ad libitum diet (AL) for two years
Number of subjects: 220
Study: 35679184

Group type: EXPERIMENTAL
Intervention: ENB-EBUS-GS
Number of subjects: 385

Group type: COMPARATOR
Intervention: EBUS-GS
Number of subjects: 385
Study: 33153063

Group type: EXPERIMENTAL
Intervention: SsObserWork
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study: 616186557

Group type: EXPERIMENTAL
Intervention: Test formulation (400 mg cefixime)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Reference formulation (400 mg cefixime)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 2
Study: 33496831

Group type: EXPERIMENTAL
Intervention: Abaloparatide (ABL), 80 μg
Number of subjects: 250

Group type: COMPARATOR
Intervention: Teriparatide (TPTD), 20 μg
Number of subjects: 250
Study: 34782927

Group type: EXPERIMENTAL
Intervention: Hamstring autograft (Auto)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Allograft (Allo)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 34596433

Group type: EXPERIMENTAL
Intervention: Autologous stem cell injection every 3 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional dressing
Number of subjects: 100
Study: 35272209

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 61
Study: 33914755

Group type: EXPERIMENTAL
Intervention: Grassland Ecological Compensation Policy (GECP)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Non-agricultural and animal husbandry income
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Herders’ age and breeding scale
Number of subjects: 449
Study: 35194047

Group type: EXPERIMENTAL
Intervention: eTRF
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: mTRF
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 33144246

Group type: EXPERIMENTAL
Intervention: Manual therapy trials
Number of subjects: 120

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 120
Study: 32842270

Group type: EXPERIMENTAL
Intervention: Alirocumab (75 mg Q2W, with dose up titration to 150 mg Q2W at week 12 if LDL-C ≥1.81 mmol/L at week 8)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 456

Group type: COMPARATOR
Intervention: Ezetimibe (10 mg daily)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Alirocumab and Ezetimibe
Number of subjects: 456
Study: 35733198

Group type: EXPERIMENTAL
Intervention: Tailored BP-limb length based on total small bowel length (TSBL): TSBL < 500 cm, BP-limb 150 cm; TSBL 500–700 cm, BP-limb 180 cm; TSBL > 700 cm, BP-limb 210 cm.
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard BP-limb length of 150 cm.
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Tailored BP-limb length based on TSBL.
Number of subjects: 212
Study: 34002069

Group type: COMPARATOR
Intervention: Enzalutamide (PROSPER trial)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Apalutamide (SPARTAN trial)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Darolutamide (ARAMIS trial)
Number of subjects: 3
Study: 35976467

Group type: EXPERIMENTAL
Intervention: Low-intensity red-light (LRL) therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cessation of LRL therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Single-focus spectacles (SFS)
Number of subjects: 102
Study: 33279888

Group type: EXPERIMENTAL
Intervention: Cryosurgery as a single regimen (group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cryosurgery combined with intralesional corticosteroids (group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cryosurgery (group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cryosurgery (group A) and Cryosurgery combined with intralesional corticosteroids (group B)
Number of subjects: 40
Study: 32227247

Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg immediate-release, twice daily for 36 months)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 336
Study: 35610566

Group type: EXPERIMENTAL
Intervention: Self-coiling catheter
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 140
Study: 32761731

Group type: EXPERIMENTAL
Intervention: 6-month preconception lifestyle intervention
Number of subjects: 577

Group type: COMPARATOR
Intervention: Control group (care as usual)
Number of subjects: 577
Study: 35296983

Group type: EXPERIMENTAL
Intervention: ISOT (Improving the safety of opioid therapy)
Number of subjects: 286
Study: 32272653

Group type: EXPERIMENTAL
Intervention: Leisure-Time Physical Activity (LTPA)
Number of subjects: 5739

Group type: EXPERIMENTAL
Intervention: Sedentary behaviour
Number of subjects: 5739

Group type: EXPERIMENTAL
Intervention: Diet Quality (Mediterranean Diet adherence)
Number of subjects: 5739

Group type: EXPERIMENTAL
Intervention: Depression risk
Number of subjects: 5739

Group type: EXPERIMENTAL
Intervention: Anthropometrics and biochemical markers
Number of subjects: 5739
Study: 36088374

Group type: EXPERIMENTAL
Intervention: Infant and Young Child Feeding (IYCF) practices
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Caregiving practices
Number of subjects: 1360
Study: 34314855

Group type: EXPERIMENTAL
Intervention: Prompt recommending brief (low effort) cognitive and/or behavioral self-regulatory strategies
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Prompt recommending more effortful cognitive or mindfulness-based strategies
Number of subjects: 112

Group type: COMPARATOR
Intervention: No intervention prompt
Number of subjects: 112
Study: 32350297

Group type: EXPERIMENTAL
Intervention: Robotic hysterectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 50
Study: 35435859

Group type: EXPERIMENTAL
Intervention: Distant Reiki applied for 20 minutes a day for 4 consecutive days
Number of subjects: 62

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 62
Study: 33769463

Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization (FISH) on the primary tumor
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Reverse transcription‐polymerase chain reaction (RT‐PCR) on the primary tumor
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Next‐generation sequencing
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Overall testing results
Number of subjects: 305
Study: 33119435

Group type: EXPERIMENTAL
Intervention: High-negativity, self-referent statements
Number of subjects: 103

Group type: COMPARATOR
Intervention: High-negativity, statements referring to another person
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Low-negativity, self-referent statements
Number of subjects: 103

Group type: COMPARATOR
Intervention: Low-negativity, statements referring to another person
Number of subjects: 103
Study: 33382529

Group type: EXPERIMENTAL
Intervention: 100 × 10^6 CAR+ T-cells (low dose)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 150 × 10^6 CAR+ T-cells (high dose)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Lymphodepleting chemotherapy (fludarabine 25 mg/m2 and cyclophosphamide 250 mg/m2 daily × 3)
Number of subjects: 68
Study: 34026713

Group type: EXPERIMENTAL
Intervention: Msingi Bora intervention (group-based responsive stimulation and nutrition education)
Number of subjects: 60
Study: 32174359

Group type: EXPERIMENTAL
Intervention: Eye tracking measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Automated forecasting decision aid
Number of subjects: 0
Study: 37233875

Group type: EXPERIMENTAL
Intervention: Kukoamine B 0.06 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Kukoamine B 0.12 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Kukoamine B 0.24 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32588042

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: CCTA (as-tested analysis)
Number of subjects: 246
Study: 32301122

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 247

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 247
Study: 34675045

Group type: EXPERIMENTAL
Intervention: Inhaled mannitol
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo (implied control)
Number of subjects: 984
Study: 32212768

Group type: EXPERIMENTAL
Intervention: Purpose-guided trial design (PGTD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pragmatic model for comparator selection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PGTD framework
Number of subjects: 0
Study: 36111243

Group type: EXPERIMENTAL
Intervention: Abdominal bandage
Number of subjects: 239

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 239
Study: 32893836

Group type: EXPERIMENTAL
Intervention: Cooked green banana in addition to standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 35927094

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33808403

Group type: EXPERIMENTAL
Intervention: Iron hydroxide adipate tartrate (IHAT) supplementation
Number of subjects: 17